News

Inozyme recently featured new clinical insights and hosted an educational symposium at the Joint Congress of the European ...
On Wednesday, Homeland Security Secretary Kristi Noem took that command a step further, refusing to even acknowledge a ...
U.S. District Judge Patricia Tolliver Giles in Virginia ordered Suri to be released immediately from a detention facility in ...
Analysis of EFX results with AI-based digital pathology underscores the potential value in evaluating histopathology response ...
The UCSF professor and frequent YouTube poster has criticized COVID-19 vaccine mandates as well as the accelerated approval ...
Q1 2025 Earnings Call Transcript May 12, 2025 Xenon Pharmaceuticals Inc. beats earnings expectations. Reported EPS is $-0.83, ...
Data from the cutaneous T-cell lymphoma (CTCL) cohort demonstrate promising clinical activity that correlates with strong immune activationOne complete response (CR), three partial responses (PR), and ...
Niktimvo (axatilimab-csfr) is a first-in-class colony stimulating factor-1 receptor (CSF-1R)-blocking antibody approved for use in the U.S. for the treatment of chronic graft-versus-host disease (GVHD ...
Data presented at American Association for Cancer Research (AACR) Annual Meeting. In April 2025, Foghorn presented new preclinical data highlighting pipeline progress for potential first-in-class ...
A swarm of anti-police activists who are calling for the abolition of the entire force are tipped to cause peak-hour chaos in ...
Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK ...
The union campaign at Garner’s RDU1 warehouse lost by a wide margin earlier this year. Organizers say they faced retaliation ...